栄研化学(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4549/E00961 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2012/09/28 | 日証協 | 114,062株 | +5.01% | 53,883株 | +136.03% | 143,530株 | -4.5% | 12,307株 | -71.19% |
2012/09/21 | 日証協 | 108,619株 | -6.25% | 22,829株 | +15.71% | 150,294株 | -4.78% | 42,713株 | -24.92% |
2012/09/14 | 日証協 | 115,864株 | +5.75% | 19,729株 | +188.65% | 157,840株 | -1.07% | 56,887株 | +8.8% |
2012/09/07 | 日証協 | 109,564株 | +2.43% | 6,835株 | -43.62% | 159,540株 | +4.38% | 52,287株 | +33.42% |
2012/08/31 | 日証協 | 106,964株 | -2.55% | 12,124株 | -39.2% | 152,840株 | -1.48% | 39,191株 | +32.21% |
2012/08/24 | 日証協 | 109,762株 | -3.85% | 19,942株 | -43.07% | 155,133株 | -0.7% | 29,644株 | +1247.45% |
2012/08/17 | 日証協 | 114,162株 | +1.6% | 35,026株 | +110.47% | 156,233株 | +1.76% | 2,200株 | -95.18% |
2012/08/10 | 日証協 | 112,362株 | +2.86% | 16,642株 | -56.18% | 153,533株 | -2.34% | 45,662株 | +221.31% |
2012/08/03 | 日証協 | 109,233株 | +0.7% | 37,978株 | +20.93% | 157,204株 | -0.97% | 14,211株 | -36.95% |
2012/07/27 | 日証協 | 108,472株 | -4.68% | 31,404株 | +15.67% | 158,743株 | +0.49% | 22,538株 | +633.9% |
2012/07/20 | 日証協 | 113,799株 | -0.2% | 27,150株 | +31.16% | 157,970株 | -0.08% | 3,071株 | +61.63% |
2012/07/13 | 日証協 | 114,028株 | +0.88% | 20,700株 | +178.04% | 158,099株 | -0.32% | 1,900株 | +111.11% |
2012/07/06 | 日証協 | 113,028株 | +5.98% | 7,445株 | -84.86% | 158,599株 | -2.1% | 900株 | -94.51% |
2012/06/29 | 日証協 | 106,653株 | -0.25% | 49,186株 | +4% | 161,999株 | +9.76% | 16,400株 | -27.42% |
2012/06/22 | 日証協 | 106,923株 | -1.6% | 47,292株 | +6.44% | 147,600株 | +2.19% | 22,596株 | +62.44% |
2012/06/15 | 日証協 | 108,662株 | +0.56% | 44,431株 | +140.86% | 144,438株 | -2.17% | 13,910株 | -70.62% |
2012/06/08 | 日証協 | 108,062株 | +2.67% | 18,447株 | +77.38% | 147,638株 | +6.04% | 47,345株 | +69.77% |
2012/06/01 | 日証協 | 105,252株 | +3.54% | 10,400株 | -82.68% | 139,228株 | +2.19% | 27,887株 | +79.34% |
2012/05/25 | 日証協 | 101,654株 | +0.02% | 60,058株 | +38.87% | 136,242株 | -1.56% | 15,550株 | +26.15% |
※株式分割は考慮していませんのでご注意ください。
Page Top